Press Releases

- Gilead to reduce momelotinib commercial royalty rates in exchange for equity in Sierra -- Amendments become effective upon Sierra Oncology closing a qualified financing - VANCOUVER, Nov. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization

VANCOUVER, Nov. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced the pricing of an underwritten public offering

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling $24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Innov8), Asahi Kasei Corporation, Accelmed Growth

WOODCLIFF LAKE, N.J., Nov. 7, 2019 /PRNewswire/ -- PDI (www.pdihc.com), a global leader in infection prevention products and solutions, today announced the acquisition of a majority share of Tru-D

RIDGEFIELD, Conn., Nov. 7, 2019 /PRNewswire/ -- Boehringer Ingelheim presented results from a new subgroup analyses that support the primary endpoint results from the Phase III INBUILD® trial that showed Ofev® (nintedanib) reduced the rate of lung function decline in patients with autoimmune-related interstitial lung diseases (ILDs). Th

BOSTON, Nov. 7, 2019 /PRNewswire/ -- National telehealth leader American Well® announced today that it has signed a definitive agreement to acquire Aligned Telehealth, a lea

PITTSBURGH, Nov. 7, 2019 /PRNewswire/ -- Highmark Health and Carnegie Mellon University (CMU) today announced a $35 million grant from Highmark Inc. to support the construction of a new student health, wellness and athletics center at CMU. The 160,000-square-foot building will, for the first time, unite criti

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- PulmOne USA Inc. has entered into a partnership agreement with Circassia Pharmaceuticals to offer the NIOX VERO® fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an integrated add-on to PulmOne's MiniBox+. The new integrated system will be offered to bot

SARASOTA, Fla., Nov. 7, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced it has entered into commercialization agreements in the conti

ALHAMBRA, Calif., Nov. 7, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, announced its consolidated financial results for the quarter ended September 30, 2019 today."We are very pleased with our third quarter financial and operationa